Targocid (teicoplanin): Reviews and patient testimonials

Targocid 200mg

Targocid is indicated in adults and in children from birth for the parenteral treatment of the following infections (see sections 4.2, 4.4 and 5.1):

• complicated skin and soft tissue infections,

• bone and joint infections,

• hospital acquired pneumonia,

• community acquired pneumonia,

• complicated urinary tract infections,

• infective endocarditis,

• peritonitis associated with continuous ambulatory peritoneal dialysis (CAPD),

• bacteraemia that occurs in association with any of the indications listed above.

Targocid is also indicated as an alternative oral treatment for Clostridium difficile infection-associated diarrhoea and colitis.

Where appropriate, teicoplanin should be administered in combination with other antibacterial agents.

Consideration should be given to official guidance on the appropriate use of antibacterial agents.

Targocid 400mg

Targocid is indicated in adults and in children from birth for the parenteral treatment of the following infections (see sections 4.2, 4.4 and 5.1):

• complicated skin and soft tissue infections,

• bone and joint infections,

• hospital acquired pneumonia,

• community acquired pneumonia,

• complicated urinary tract infections,

• infective endocarditis,

• peritonitis associated with continuous ambulatory peritoneal dialysis (CAPD),

• bacteraemia that occurs in association with any of the indications listed above.

Targocid is also indicated as an alternative oral treatment for Clostridium difficile infection-associated diarrhoea and colitis.

Where appropriate, teicoplanin should be administered in combination with other antibacterial agents.

Consideration should be given to official guidance on the appropriate use of antibacterial agents.